You just read:

Profectus BioSciences Awarded NIH Contract for up to $22.25 Million to Develop Multi-Component Vaccine for Ebola, Marburg, and Lassa Viruses

News provided by

Profectus BioSciences

Oct 02, 2017, 08:30 ET